502 related articles for article (PubMed ID: 26873329)
1. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
[TBL] [Abstract][Full Text] [Related]
4. Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
Bagnato G; Bitto A; Irrera N; Pizzino G; Sangari D; Cinquegrani M; Roberts W; Atteritano M; Altavilla D; Squadrito F; Bagnato G; Saitta A
Arthritis Res Ther; 2013 Sep; 15(5):R120. PubMed ID: 24286160
[TBL] [Abstract][Full Text] [Related]
5. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
[TBL] [Abstract][Full Text] [Related]
6. Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis.
Hua-Huy T; Le-Dong NN; Duong-Quy S; Bei Y; Rivière S; Tiev KP; Nicco C; Chéreau C; Batteux F; Dinh-Xuan AT
J Breath Res; 2015 Jun; 9(3):036007. PubMed ID: 26079155
[TBL] [Abstract][Full Text] [Related]
7. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
8. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
[TBL] [Abstract][Full Text] [Related]
9. Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis.
Bagnato GL; Irrera N; Pizzino G; Santoro D; Roberts WN; Bagnato G; Pallio G; Vaccaro M; Squadrito F; Saitta A; Altavilla D; Bitto A
Clin Sci (Lond); 2018 Jan; 132(2):231-242. PubMed ID: 29237724
[TBL] [Abstract][Full Text] [Related]
10. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
Front Immunol; 2019; 10():1861. PubMed ID: 31481954
[TBL] [Abstract][Full Text] [Related]
11. The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.
Marut WK; Kavian N; Servettaz A; Nicco C; Ba LA; Doering M; Chéreau C; Jacob C; Weill B; Batteux F
J Invest Dermatol; 2012 Apr; 132(4):1125-32. PubMed ID: 22277946
[TBL] [Abstract][Full Text] [Related]
12. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.
Kavian N; Servettaz A; Mongaret C; Wang A; Nicco C; Chéreau C; Grange P; Vuiblet V; Birembaut P; Diebold MD; Weill B; Dupin N; Batteux F
Arthritis Rheum; 2010 Nov; 62(11):3477-87. PubMed ID: 20583103
[TBL] [Abstract][Full Text] [Related]
13. Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice.
Jiang C; Huang H; Liu J; Wang Y; Lu Z; Xu Z
Int J Mol Sci; 2012; 13(7):8293-8307. PubMed ID: 22942703
[TBL] [Abstract][Full Text] [Related]
14. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
[TBL] [Abstract][Full Text] [Related]
15. Fasudil prevents calcium oxalate crystal deposit and renal fibrogenesis in glyoxylate-induced nephrolithic mice.
Hu H; Chen W; Ding J; Jia M; Yin J; Guo Z
Exp Mol Pathol; 2015 Apr; 98(2):277-85. PubMed ID: 25697583
[TBL] [Abstract][Full Text] [Related]
16. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.
Fineschi S; Bongiovanni M; Donati Y; Djaafar S; Naso F; Goffin L; Argiroffo CB; Pache JC; Dayer JM; Ferrari-Lacraz S; Chizzolini C
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):458-65. PubMed ID: 18458239
[TBL] [Abstract][Full Text] [Related]
17. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
18. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis.
Bagnato G; Bitto A; Pizzino G; Irrera N; Sangari D; Cinquegrani M; Roberts WN; Matucci Cerinic M; Squadrito F; Altavilla D; Bagnato G; Saitta A
Rheumatology (Oxford); 2013 Aug; 52(8):1377-86. PubMed ID: 23620550
[TBL] [Abstract][Full Text] [Related]
20. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
